Brindley P J, Heath S, Waters A P, McCutchan T F, Sher A
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health,, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7754-8. doi: 10.1073/pnas.88.17.7754.
Stable resistance to the anthelmintic hycanthone can be produced in the human blood fluke Schistosoma mansoni by exposing immature parasites in mice to the drug. Within a single generation, genomic rearrangements, detected as rRNA-encoding DNA restriction fragment length polymorphisms (RFLPs), accompany the appearance of resistance in this model. One of these RFLPs, an approximately 3.6-kilobase BamHI fragment, was shown previously to associate consistently with resistance in independent generations of the JHU strain of S. mansoni. To characterize the genetic changes responsible for this RFLP, the fragment was cloned and sequenced. A comparison of the cloned fragment with a normal 18S rRNA gene demonstrated that the drug resistance-associated RFLP fragment arises through the addition of 732 base pairs into an 18S rRNA gene, 134 base pairs downstream of the junction of the intergenic spacer and the mature 18S rRNA gene. The mutation is nonrandom, targets one, or a few only, of the 100 or so copies of the ribosomal genes, and may represent the incomplete duplication of the gene since the inserted element is identical in sequence to the region contiguous to it. The sequence spanning the junction of the insertion and the original 18S rRNA gene was used as a specific primer for the BamHI RFLP in PCR experiments. The analysis conclusively demonstrated that the mutation is induced rather than selected by the drug since the junctional sequence was not detectable in the drug-sensitive parent population of schistosomes. In addition, analysis of four, independently derived, resistant lines indicated that the same region of the gene was mutated each time. Together, these data demonstrate that reproducible changes are induced during the acquisition of resistance in schistosomes and suggest that the resistant phenotype is induced rather than selected from preexisting forms.
通过将未成熟的寄生虫暴露于药物中,可在人体血吸虫曼氏血吸虫中产生对驱虫药海恩酮的稳定抗性。在这一模型中,单代内基因组重排(检测为编码rRNA的DNA限制性片段长度多态性,即RFLP)伴随着抗性的出现。其中一种RFLP,即一个约3.6千碱基的BamHI片段,先前已被证明在曼氏血吸虫JHU品系的独立世代中始终与抗性相关。为了表征导致这种RFLP的基因变化,对该片段进行了克隆和测序。将克隆片段与正常的18S rRNA基因进行比较表明,与耐药性相关的RFLP片段是通过在18S rRNA基因中添加732个碱基对产生的,该添加发生在基因间隔区与成熟18S rRNA基因交界处下游134个碱基对处。该突变是非随机的,仅针对100个左右核糖体基因中的一个或几个,并且可能代表基因的不完全重复,因为插入元件的序列与其相邻区域相同。跨越插入片段与原始18S rRNA基因交界处的序列在PCR实验中用作BamHI RFLP的特异性引物。分析最终证明该突变是由药物诱导而非选择产生的,因为在药物敏感的血吸虫亲代群体中未检测到交界序列。此外,对四个独立衍生的抗性品系的分析表明,每次基因的同一区域都会发生突变。这些数据共同表明,在血吸虫获得抗性的过程中会诱导产生可重复的变化,并表明抗性表型是由药物诱导产生的,而非从预先存在的形式中选择出来的。